C. Cunningham

发表

Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others.

S. Pinder, H. Earl, D. Rea, 2016, Journal of the National Cancer Institute.

In situ detection of HER2:HER2 and HER2:HER3 protein–protein interactions demonstrates prognostic significance in early breast cancer

J. Bartlett, D. Cameron, E. Mallon, 2012, Breast Cancer Research and Treatment.

Proximity ligation assays for isoform‐specific Akt activation in breast cancer identify activated Akt1 as a driver of progression

G. Kerr, J. Bartlett, D. Cameron, 2012, The Journal of pathology.

G. Kerr, J. Bartlett, D. Cameron, 2013, The Journal of pathology.